MichelTTorbeyMD

Neurology • Albuquerque, NM

Spinal Disorder, Vascular Neurology, Neurocritical Care

Professor of Neurology, University of New Mexico

Join to view full profile

Dr. Torbey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Torbey's full profile

Already have an account?

Office
900 Camino de Salud
Albuquerque, NM 87131

Education & Training

UMass Chan Medical SchoolResidency, Neurology, 1996 - 1999
Johns Hopkins UniversityInternship, Internal Medicine, 1995 - 1996
American University of Beirut Faculty of MedicineClass of 1993

Certifications & Licensure

NM State Medical License 2018 - 2025
OK State Medical License 2024 - 2025
OH State Medical License 2010 - 2019
WI State Medical License 2003 - 2013
MA State Medical License 1997 - 2004
MD State Medical License 2001 - 2003
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology

Awards, Honors, & Recognition

Fellow (FCCM) American College of Critical Care Medicine

Clinical Trials

Albumin in Acute Ischemic Stroke Trial Start of enrollment: 2006 Jun 01
Terminated
Phase 3
Cardiac Arrest Recovery EEG Study Start of enrollment: 2007 Aug 01
Unknown status
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Start of enrollment: 2009 Jul 01
Completed
Phase 3
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living Start of enrollment: 2008 Nov 01
Completed
Phase 1
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Start of enrollment: 2012 Apr 01
Completed
Phase 3
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals Start of enrollment: 2013 Jun 13
Completed
Phase 2
Study of Procoagulation Markers in Stroke Patients Start of enrollment: 2012 Aug 01
Completed
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III Start of enrollment: 2013 Dec 30
Completed
Phase 3
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN) Start of enrollment: 2015 Jan 01
Withdrawn
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

31 citations
Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis
Ciaran J. Powers, David Dornbos, Michael Mlynash, Deepak Gulati, Michel T. Torbey
AJNR. American Journal of Neuroradiology. 2019-06-01
2848 citations
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Gregory W. Albers, Michael P. Marks, Stephanie Kemp, Soren Christensen, Jenny P Tsai
The New England Journal of Medicine. 2018-01-24
20 citations
Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results.
Abdoreza Ghoreishi, Shahram Arsang-Jang, Ziad Sabaa-Ayoun, Nawaf Yassi, P N Sylaja
Journal of Stroke and Cerebrovascular Diseases. 2020-12-01

Press Mentions

National Leader in Neurology and Neurocritical Care Chosen to Lead at OU Health, University of Oklahoma College of MedicineAugust 26th, 2024
How Should Neurologists Talk to Decision-Makers for Patients in the Neuroscience ICU?: There's Room for Improvement, Surveys FoundMay 18th, 2017
Drug Use and Unique MRI Pattern Associated with Amnestic SyndromeMarch 16th, 2017
Join now to see all

Professional Memberships

American College of Critical Care Medicine - SCCM
Fellow